Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron D Goldberg

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Current Oncology Reports|March 25, 2019
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic TargetsMaximilian Stahl, Aaron D Goldberg
Haematologica|November 13, 2025
An emerging triplet option for newly diagnosed <i>FLT3-</i>mutated acute myeloid leukemiaLeora Boussi, Aaron D Goldberg
Blood|November 5, 2016
Down for the count in acute myeloid leukemiaAaron D Goldberg, Martin S Tallman
Haematologica|March 3, 2020
Leukemia stem cell gene expression signatures contribute to acute myeloid leukemia risk stratificationKatherine L B Knorr, Aaron D Goldberg
Circulation|October 16, 2013
Tumors metastatic to the heartAaron D Goldberg, Ron Blankstein, Robert F Padera
Leukemia & Lymphoma|September 14, 2021
Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journeyMaximilian Stahl, Martin S Tallman, Aaron D Goldberg
Cell|February 27, 2007
Epigenetics: a landscape takes shapeAaron D Goldberg, C David Allis, Emily Bernstein
Current Opinion in Genetics & Development|February 16, 2010
New functions for an old variant: no substitute for histone H3.3Simon J Elsaesser, Aaron D Goldberg, C David Allis
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Clinical Development of PD-1 Blockade in Hematologic MalignanciesMatthew J Pianko, Aaron D Goldberg, Alexander M Lesokhin
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2002
Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA)Rainer B Lanz, Bahram Razani, Aaron D Goldberg, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Oncology Reports|March 25, 2019
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic TargetsMaximilian Stahl, Aaron D Goldberg
Haematologica|November 13, 2025
An emerging triplet option for newly diagnosed <i>FLT3-</i>mutated acute myeloid leukemiaLeora Boussi, Aaron D Goldberg
Blood|November 5, 2016
Down for the count in acute myeloid leukemiaAaron D Goldberg, Martin S Tallman
Haematologica|March 3, 2020
Leukemia stem cell gene expression signatures contribute to acute myeloid leukemia risk stratificationKatherine L B Knorr, Aaron D Goldberg
Circulation|October 16, 2013
Tumors metastatic to the heartAaron D Goldberg, Ron Blankstein, Robert F Padera
Leukemia & Lymphoma|September 14, 2021
Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journeyMaximilian Stahl, Martin S Tallman, Aaron D Goldberg
Cell|February 27, 2007
Epigenetics: a landscape takes shapeAaron D Goldberg, C David Allis, Emily Bernstein
Current Opinion in Genetics & Development|February 16, 2010
New functions for an old variant: no substitute for histone H3.3Simon J Elsaesser, Aaron D Goldberg, C David Allis
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Clinical Development of PD-1 Blockade in Hematologic MalignanciesMatthew J Pianko, Aaron D Goldberg, Alexander M Lesokhin
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2002
Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA)Rainer B Lanz, Bahram Razani, Aaron D Goldberg, et al.
Pageof 7